Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

It also heralded a change in strategy, with CEO Robert Davis saying that the company is undergoing "a multiyear optimization ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Discover why Darling Ingredients' unique position in sustainable food and renewable fuels offers long-term upside.

Partially a result, Novo Nordisk has steadily declined since last summer. Over the past year, NVO shares are down more than ...

The FTSE 100 enjoyed another leap towards record territory as the index pushed around 0.7 per cent higher on Tuesday, ...

Consumers are already stretched thin, so rate cuts may not significantly boost spending or spark runaway inflation as many ...

Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth ...

FDA’s latest whitepaper shows how scalable quality management investments in pharma reduce costs, improve reliability, and ...

Novo Nordisk just lost $100 billion in market value. Here's what the crash means for ResMed — and why investor sentiment may ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...